The invention refers to a human antibody, or its functional fragments, directed against the HCV E2 glycoprotein, able to have a neutralizing activity in vivo; a composition for anti-HCV therapy comprising in a therapeutically effective amount the antibody; a composition for topical use in gel, creme, ointment and ovule formulations; the use of the antibody for validating anti-HCV vaccines.

 
Web www.patentalert.com

< Method for treating hepatitis C virus with omega interferon

< Lentiviral vectors derived from SIVsmm/PBj14, method for their production and uses thereof

> Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof

> Methods for detection of genetic disorders

~ 00610